Scarica l'app Stockscreener
3.80
2.06%
-0.08
Dopo l'orario di chiusura:
3.75
-0.05
-1.32%
Precedente Chiudi:
$3.88
Aprire:
$3.77
Volume 24 ore:
1.07M
Relative Volume:
0.41
Capitalizzazione di mercato:
$325.24M
Reddito:
-
Utile/perdita netta:
$-36.95M
Rapporto P/E:
-4.5238
EPS:
-0.84
Flusso di cassa netto:
$-33.46M
1 W Prestazione:
-12.64%
1M Prestazione:
-21.97%
6M Prestazione:
+27.95%
1 anno Prestazione:
-49.80%
Intervallo 1D:
$3.71
$3.905
Intervallo di 1 settimana:
$3.71
$4.495
Portata 52W:
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
Nome
Larimar Therapeutics Inc
Settore
Industria
Telefono
844-511-9056
Indirizzo
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Confronta LRMR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.80 | 332.09M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-29 | Iniziato | Truist | Buy |
| 2024-10-16 | Iniziato | Oppenheimer | Outperform |
| 2024-10-03 | Iniziato | Wedbush | Outperform |
| 2024-10-02 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-04 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-03 | Iniziato | Leerink Partners | Outperform |
| 2023-11-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-19 | Iniziato | Guggenheim | Buy |
| 2022-02-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-02-01 | Iniziato | William Blair | Outperform |
Mostra tutto
Larimar Therapeutics Inc Borsa (LRMR) Ultime notizie
How geopolitical risks impact Larimar Therapeutics Inc. (ZA71) stockWeekly Investment Report & Free Reliable Trade Execution Plans - newser.com
Why Larimar Therapeutics Inc. stock is favored by pension fundsWeekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Will Larimar Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
What institutional flow reveals about Larimar Therapeutics Inc.July 2025 Catalysts & Smart Allocation Stock Reports - newser.com
What machine learning models say about Larimar Therapeutics Inc.Earnings Trend Report & Capital Efficient Trade Techniques - newser.com
How moving averages guide Larimar Therapeutics Inc. tradingTrade Risk Summary & Community Trade Idea Sharing - newser.com
Why Larimar Therapeutics Inc. (ZA71) stock stays undervaluedSwing Trade & Community Verified Trade Alerts - newser.com
Detecting price anomalies in Larimar Therapeutics Inc. with AIJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Applying chart zones and confluence areas to Larimar Therapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
Larimar Therapeutics Inc. stock retracement – recovery analysisDay Trade & Free Community Consensus Stock Picks - newser.com
How Larimar Therapeutics Inc. stock trades during market volatility2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
How Larimar Therapeutics Inc. (ZA71) stock behaves in tightening cycles2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
Is Larimar Therapeutics Inc. (ZA71) stock positioned for digital growth era2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Will Larimar Therapeutics Inc. stock benefit from automationEarnings Beat & AI Enhanced Trading Alerts - newser.com
Is Larimar Therapeutics Inc. (ZA71) stock worth buying before Fed actionWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Price action breakdown for Larimar Therapeutics Inc.Weekly Gains Summary & Safe Capital Allocation Plans - newser.com
Custom watchlist performance reports with Larimar Therapeutics Inc.July 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Will Larimar Therapeutics Inc. stock gain from lower inflationSwing Trade & Safe Entry Point Alerts - newser.com
What makes Larimar Therapeutics Inc. stock attractive to growth fundsJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
Pattern recognition hints at Larimar Therapeutics Inc. upsidePortfolio Update Report & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-11-01 00:49:57 - newser.com
Multi factor analysis applied to Larimar Therapeutics Inc.July 2025 Chart Watch & Safe Entry Point Identification - newser.com
What analysts say about Larimar Therapeutics Inc ZA71 stockDividend Aristocrats List & Superior Capital Growth - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Larimar Therapeutics, Inc. (LRMR) And Encourages Shareholders to Reach Out - ACCESS Newswire
2025-10-31 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Larimar Therapeutics, Inc. (LRMR) And Encourages Shareholders to Reach Out | NDAQ:LRMR | Press Release - Stockhouse
Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):